About this trial
The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.
Eligibility criteria
Qualifiers
Men and women, age 18-45
Treatment-seeking individuals who meet criteria for a primary DSM-5 diagnosis of primary social anxiety disorder (SAD) or body dysmorphic disorder (BDD) based on the SCID-5-RV
Fluent in English and willing to provide informed consent.
Men and women, age 18-45
Disqualifiers
Score < 80 based on WRAT5 Word Reading Subtest
fMRI contraindications (e.g., electronic medical devices such as pacemakers, implanted defibrillators, etc.; metal implants not approved for MRI; pregnancy; claustrophobia)
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy
Treatment groups
Sponsors and collaborators
University of Washington
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator